EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
- PMID: 20402746
- DOI: 10.1111/j.1468-1331.2010.02999.x
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Abstract
Background and objectives: This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005.
Methods: Studies were identified using the Cochrane Database and Medline. Trials were classified according to the aetiological condition. All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies. Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting.
Results: Most large RCTs included patients with diabetic polyneuropathies and post-herpetic neuralgia, while an increasing number of smaller studies explored other conditions. Drugs generally have similar efficacy in various conditions, except in trigeminal neuralgia, chronic radiculopathy and HIV neuropathy, with level A evidence in support of tricyclic antidepressants (TCA), pregabalin, gabapentin, tramadol and opioids (in various conditions), duloxetine, venlafaxine, topical lidocaine and capsaicin patches (in restricted conditions). Combination therapy appears useful for TCA-gabapentin and gabapentin-opioids (level A).
Conclusions: There are still too few large-scale comparative studies. For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.
Similar articles
-
EFNS guidelines on pharmacological treatment of neuropathic pain.Eur J Neurol. 2006 Nov;13(11):1153-69. doi: 10.1111/j.1468-1331.2006.01511.x. Eur J Neurol. 2006. PMID: 17038030
-
[Evidence-based pharmacotherapy of neuropathic pain syndromes].MMW Fortschr Med. 2004 Dec 9;146(50):49-51. MMW Fortschr Med. 2004. PMID: 15658522 Review. German.
-
Combination pharmacotherapy for the treatment of neuropathic pain in adults.Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD008943. doi: 10.1002/14651858.CD008943.pub2. Cochrane Database Syst Rev. 2012. PMID: 22786518 Free PMC article. Review.
-
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2. Cochrane Database Syst Rev. 2017. PMID: 28779491 Free PMC article. Review.
-
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.Clin Ther. 2003 Jan;25(1):81-104. doi: 10.1016/s0149-2918(03)90011-7. Clin Ther. 2003. PMID: 12637113 Review.
Cited by
-
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs.Ther Adv Musculoskelet Dis. 2024 May 23;16:1759720X241253656. doi: 10.1177/1759720X241253656. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 38799611 Free PMC article. Review.
-
A Comprehensive Narrative Review of Neuropathic Pain: From Pathophysiology to Surgical Treatment.Cureus. 2024 Apr 11;16(4):e58025. doi: 10.7759/cureus.58025. eCollection 2024 Apr. Cureus. 2024. PMID: 38738050 Free PMC article. Review.
-
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder Associated with Chronic Pain: An Observational Study in a Spanish Population.Pain Ther. 2024 Jun;13(3):621-635. doi: 10.1007/s40122-024-00597-3. Epub 2024 Apr 29. Pain Ther. 2024. PMID: 38683448 Free PMC article.
-
Pain in Long-Term Cancer Survivors: Prevalence and Impact in a Cohort Composed Mostly of Breast Cancer Survivors.Cancers (Basel). 2024 Apr 20;16(8):1581. doi: 10.3390/cancers16081581. Cancers (Basel). 2024. PMID: 38672663 Free PMC article.
-
Pregabalin-induced delayed cutaneous hypersensitivity reaction occurring after 40 days of use: a case report.J Int Med Res. 2024 Apr;52(4):3000605241245004. doi: 10.1177/03000605241245004. J Int Med Res. 2024. PMID: 38635889 Free PMC article.
References
-
- Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-1635.
-
- Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136: 380-387.
-
- Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006; 7: 281-289.
-
- Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence based recommendations. Pain 2007; 132: 237-251. (class I SR).
-
- Finnerup NB, Jensen TS. Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis. Nat Clin Pract Neurol 2006; 2: 107-115. (class I SR).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical